Cargando…
Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells
Autores principales: | Casado, Pedro, Wilkes, Edmund H., Miraki-Moud, Farideh, Hadi, Marym Mohammad, Rio-Machin, Ana, Rajeeve, Vinothini, Pike, Rebecca, Iqbal, Sameena, Marfa, Santiago, Lea, Nicholas, Best, Steven, Gribben, John, Fitzgibbon, Jude, Cutillas, Pedro R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949212/ https://www.ncbi.nlm.nih.gov/pubmed/29626197 http://dx.doi.org/10.1038/s41375-018-0032-1 |
Ejemplares similares
-
Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes
por: Casado, Pedro, et al.
Publicado: (2023) -
Sequence and Structure-Based Analysis of Specificity Determinants in Eukaryotic Protein Kinases
por: Bradley, David, et al.
Publicado: (2021) -
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs
por: Gerdes, Henry, et al.
Publicado: (2021) -
Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia
por: Waclawiczek, Alexander, et al.
Publicado: (2020) -
eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors
por: Hijazi, Maruan, et al.
Publicado: (2022)